SPY304.32+1.35 0.45%
DIA254.29-0.06 -0.02%
IXIC9,489.87+120.88 1.29%

Passage Bio Q1 EPS $(1.000) Misses $(0.450) Estimate

Passage Bio (NASDAQ:PASG) reported quarterly losses of $(1.000) per share which missed the analyst consensus estimate of $(0.450) by 122.22 percent.

Benzinga · 05/11/2020 11:19

Passage Bio (NASDAQ:PASG) reported quarterly losses of $(1.000) per share which missed the analyst consensus estimate of $(0.450) by 122.22 percent.